Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-25-004515
Filing Date
2025-08-05
Accepted
2025-08-05 10:22:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6879
  Complete submission text file 0001085146-25-004515.txt   8761
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Subject) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92704 | Film No.: 251183333
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1 GEORGE STREET EDINBURGH X0 EH2 2LL
Business Address 1 GEORGE STREET EDINBURGH X0 EH2 2LL 0131 245 2552
Aberdeen Group plc (Filed by) CIK: 0001716774 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231